content top

Restoration of Accommodation: A Refractive Surgical Procedure for the Vitreoretinal Surgeon

Media not available due to technical recording problems. EVRS is very sorry for the inconvenience.   An introduction to the novel Zonular Capture Haptics technology for Accommodating-Disaccomodating IOL\’s and discuss the role of vitreoretinal surgery in the activation of the accommodation. Four generations of ZCH-based devices have been implanted in as many as nine rhesus monkey eyes at the Wisconsin National Primate Research...

Read More

Adult Vitelliform Macular Dystrophy Treated with Bevacizumab

Naomi S. Falk, MD (Albany, NY), Paul M. Beer, MD (Albany, NY), Amjad M. Hammad, MD (Albany, NY) PURPOSE: To explore contrast between objective improvement and visual function. METHODS: Study design is a case report of a 55 year old woman who received 2 injections of intravitreal Bevacizumab for Adult Vitelliform dystrophy due to complaints of blurred vision and distortion. She had received 4 prior injections of Pegaptanib sodium without...

Read More

Suspension Phase Microsphere Immunoassay of Bevacizumab Levels in Ocular Fluids and Sera

Susan J. Wong, PhD (Albany, NY), Paul M. Beer, MD (Albany, NY) PURPOSE: Bevacizumab, a humanized monoclonal antibody targeting VEGF, is currently injected into vitreous humor to treat age-related macular degeneration. proliferative diabetic retinopathy and other conditions associatd with vascular leakage and angiogenesis. We developed a suspension phase microsphere immunoassay of free bevacizumab levels in ocular fluids and serum to enable...

Read More

Six-month Follow-up on 50 Consecutive Patients with Intravitreal Bevacizumab Injections for Neovascular Age Related Macular Degeneration

http://www.evrs.eu/medias/2006/congress/Six-month-Follow-up-on-50-Consecutive-Patients-with-Intravitreal-Bevacizumab-Injections-for-Neovascular-Age-Related-Macular-Degeneration.swf Samira Khan, (Albany, NY), Paul M. Beer, MD (Albany, NY), Naomi S. Falk, MD (Albany, NY), Amjad Hammad, MD (Albany, NY), Martin O’Malley, MD (Albany, NY) PURPOSE: 6 months results of intravitreal Bevacizumab on patients with neovascular ARMD. METHODS: A...

Read More

Vitreous Levels of Unbound Bevacizumab and Unbound Vascular Endothelial Growth Factors in Two Human Subjects

http://www.evrs.eu/medias/2006/congress/Vitreous-Levels-of-Unbound-Bevacizumab-and-Unbound-Vascular-Endothelial-Growth-Factors-in-Two-Human-Subjects.swf Paul M. Beer, MD (Albany, NY), Susan Wong, PhD (Albany, NY), Naomi S. Falk, MD (Albany, NY), Amjad Hammad, MD (Albany, NY), Samira Khan, (Albany, NY), MartinO’Malley, MD (Albany, NY) PURPOSE: Determination of vitreous levels of unbound VEGF and unbound bevacizumab in two patients who...

Read More
content top